Skip to content

Exploring the relationship between microdosing, personality and emotional insight: A prospective study

Hannah Marie Dressler, Stephen Bright, Vince Polito

Journal of Psychedelic Studies March 26, 2021 DOI: 10.1556/2054.2021.00157 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Prospective study Peer reviewed
Sample size 76
Population Microdosers
Intervention Microdosing
Duration 31-day follow-up
Topics Microdosing
Keywords Conscientiousness Neuroticism Personality Extraversion and introversion Alexithymia Clinical psychology
Citations 12
Key points Microdosing was associated with increased conscientiousness and decreased neuroticism over 31 days.

Abstract

Abstract Backround and aims Having entered the recent public and research zeitgeist, microdosing involves consuming sub-perceptual doses of psychedelic drugs, allegedly to enhance performance, creativity, and wellbeing. The results of research to date have been mixed. Whereas most studies have reported positive impacts of microdosing, some microdosers have also reported adverse effects. In addition, research to date has revealed inconsistent patterns of change in personality traits. This prospective study explored the relationship between microdosing, personality change, and emotional awareness.

Methods: Measures of personality and alexithymia were collected at two time points. 76 microdosers participated at baseline. Invitations to a follow-up survey were sent out after 31 days, and 24 participants were retained.

Results: Conscientiousness increased, while neuroticism decreased across these time points ( n = 24). At baseline ( N = 76), neuroticism was associated with alexithymia. In addition, neuroticism correlated negatively with duration of prior microdosing experience, and extraversion correlated positively with both duration of prior microdosing experience and lifetime number of microdoses.

Conclusion: These results suggest that microdosing might have an impact on otherwise stable personality traits.

Comparable studies

Other observational and cohort studies on microdosing, most cited first.

Study Year Design Participants
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers Respondents recruited from online forums 2019 Observational study
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing Individuals planning a weekly microdosing regimen 2021 Prospective observational study n = 81
Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration. More than a thousand individuals from 59 countries 2019 Observational cohort n = 1,000
Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls Psilocybin microdosers and non-microdosing comparators 2022 Naturalistic observational study n = 1,133
Nonlinear Pharmacokinetics of Oral Quinidine and Verapamil in Healthy Subjects: A Clinical Microdosing Study Healthy subjects 2011 Observational cohort

Citations in the library

Cited by 12

and 7 more in the library

Cites 27

and 22 more in the library

Explore topics